We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
(-2.6%)
Cap. Flow
-$4.15B
Cap. Flow
% of AUM
-9.34%
Top 10 Holdings %
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$309M |
| 2 |
ExxonMobil
XOM
|
+$302M |
| 3 |
Amazon
AMZN
|
+$291M |
| 4 |
Citigroup
C
|
+$253M |
| 5 |
Shopify
SHOP
|
+$238M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$383M |
| 2 |
Johnson & Johnson
JNJ
|
+$312M |
| 3 |
JPMorgan Chase
JPM
|
+$285M |
| 4 |
AT&T
T
|
+$191M |
| 5 |
Dollar General
DG
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.63% |
| 2 | Financials | 15.61% |
| 3 | Technology | 14.28% |
| 4 | Consumer Discretionary | 13.21% |
| 5 | Industrials | 5.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRNS
2751
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $107K | ﹤0.01% |
+26,813
| New | +$132K |
|
2752
Radiant Logistics
RLGT
$400M
| $106K | ﹤0.01% |
20,853
-36,107
| -63% | -$202K |
|
|
SONDW
2753
CALL
DELISTED
Sonder Holdings Inc Warrants
SONDW
| $105K | ﹤0.01% |
84,567
-27,757
| -25% | -$4.22K |
|
|
GAN
2754
DELISTED
GAN Ltd
GAN
| $105K | ﹤0.01% |
69,800
-67,907
| -49% | -$114K |
|
2755
Asure Software
ASUR
$242M
| $105K | ﹤0.01% |
+11,200
| New | +$79.9K |
|
2756
Pyxis Tankers
PXS
$47M
| $104K | ﹤0.01% |
+21,606
| New | +$106K |
|
2757
Ceragon Networks
CRNT
$188M
| $104K | ﹤0.01% |
54,200
-106,638
| -66% | -$200K |
|
|
BHIL
2758
DELISTED
Benson Hill, Inc.
BHIL
| $103K | ﹤0.01% |
+1,157
| New | +$113K |
|
2759
Telecom Argentina
TEO
$5.84B
| $99.3K | ﹤0.01% |
18,214
-64,531
| -78% | -$277K |
|
2760
CI&T Inc
CINT
$423M
| $96.5K | ﹤0.01% |
14,849
+1,114
| +8% | +$8.73K |
|
2761
PUT
Caterpillar
CAT
$361B
| $95.8K | ﹤0.01% |
+400
| New | +$87.1K |
|
|
DCH
2762
Dauch Corp
DCH
$1.31B
| $95.3K | ﹤0.01% |
+12,189
| New | +$109K |
|
2763
DarioHealth
DRIO
$69.2M
| $95K | ﹤0.01% |
1,109
-2,782
| -71% | -$250K |
|
|
CZOO
2764
DELISTED
Cazoo Group Ltd
CZOO
| $94.2K | ﹤0.01% |
294
-410
| -58% | -$243K |
|
|
DDL
2765
Dingdong
DDL
$525M
| $92.3K | ﹤0.01% |
+21,608
| New | +$84.8K |
|
2766
Quest Resource Holding
QRHC
$27.6M
| $91.6K | ﹤0.01% |
+14,991
| New | +$112K |
|
|
KNTE
2767
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $91.2K | ﹤0.01% |
14,944
+3,492
| +30% | +$28.4K |
|
|
SURF
2768
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $91K | ﹤0.01% |
110,928
-96,025
| -46% | -$94.7K |
|
|
PETWW
2769
CALL
DELISTED
Wag! Group Co Warrant
PETWW
| $90.5K | ﹤0.01% |
29,388
| – | – |
|
|
BGRY
2770
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
| $90K | ﹤0.01% |
150,000
+97,219
| +184% | +$109K |
|
|
KZR
2771
DELISTED
Kezar Life Sciences
KZR
| $89.8K | ﹤0.01% |
1,275
-64,569
| -98% | -$4.79M |
|
2772
Vivid Seats
SEAT
$81.6M
| $88.7K | ﹤0.01% |
608
-1,369
| -69% | -$213K |
|
2773
Spero Therapeutics
SPRO
$68.9M
| $88.1K | ﹤0.01% |
50,917
-135,653
| -73% | -$253K |
|
2774
CS Disco
LAW
$271M
| $87.7K | ﹤0.01% |
13,883
| – | – |
|
|
RTB
2775
RTB Digital
RTB
$230M
| $87K | ﹤0.01% |
541
| – | – |
|
Similar funds
Marshall Wace's Q4 2022 Portfolio in Review
As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.
Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.
- Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
- Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
- Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
- Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
- Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
- Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.
Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.